ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque Psoriasis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00192517
Recruitment Status : Completed
First Posted : September 19, 2005
Last Update Posted : April 3, 2009
Sponsor:
Information provided by:
MedImmune LLC

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2004
  Actual Study Completion Date : September 2004